Top Senate Dem quietly inserts Iran poison pill into China bill | WHAT REALLY HAPPENED X-Frame-Options: SAMEORIGIN

Top Senate Dem quietly inserts Iran poison pill into China bill

It seems like a basic transparency measure. But some Senate Democrats worry that an amendment quietly added to a China-related bill could be a stealth poison pill for diplomacy with Iran.

Shortly before the Strategic Competition Act was set to be marked up by the Senate Foreign Relations Committee, chairman Bob Menendez (D–N.J.) and ranking member Jim Risch (R–Idaho) inserted an amendment that vastly expands the reporting requirements for international agreements.

The amendment requires the State Department to provide detailed reports to Congress within five days after it “approves the negotiation or conclusion” of an international agreement or “non-binding instrument” with “an important effect on the foreign policy of the United States.”

While the amendment was backed by some legal experts, two congressional aides and an activist speaking on condition of anonymity expressed concern to Responsible Statecraft that it could affect ongoing negotiations in Vienna, where the Biden administration is in talks with five other world powers to constrain Iran’s nuclear program.

Tags:

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA